Isabel Tian
Senior Director, Scientific Affairs, Cellares
Isabel Tian is listed as Senior Director, Scientific Affairs, Cellares. Isabel is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Isabel. Is this you? Claim this profile.
About
Isabel Tian is the Senior Director of Scientific Affairs at Cellares. She is passionate about accelerating patient access to life-saving therapies through automation and innovation. With a background spanning process development, CMC, and scientific communication, Isabel bridges science and business strategy to shape product roadmaps, guide executive decision-making, and position Cellares as the global leader in industrialized cell therapy manufacturing. She holds a B.S. in Chemical Engineering from New York University and a Ph.D. in Nanoscale Engineering from SUNY Polytechnic Institute.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency? Speaker · 19 January 2027
- Spotlight: Automating your way to regulatory confidence: a comparability Case Study Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Isabel at events on B2DB.
- Greg Russotti Chief Technology & Manufacturing Officer · Century Therapeutics 1 shared session
- Jeffrey Cram Vice President of Process Development · Elevatebio 1 shared session
- Mamta Kalra Vice President Process and Analytical Development · Immatics 1 shared session
- Sarah Yuan Chief Technology Officer · Cabaletta Bio 1 shared session